Other studies suggested that metformin and phenformin, antidiabetic drugs that also interfere with energetic metabolism in cancer cells, show promise in decreasing resistance through the inhibition of ABC transporters in breast cancer [32,80,173]. The gene discussed is ABCG2; the disease is breast carcinoma.